These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32637482)

  • 1. Treatment effects on neurometabolite levels in schizophrenia: A meta-analysis dataset of proton magnetic resonance spectroscopy.
    Kubota M; Moriguchi S; Takahata K; Nakajima S; Horita N
    Data Brief; 2020 Aug; 31():105862. PubMed ID: 32637482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
    Kubota M; Moriguchi S; Takahata K; Nakajima S; Horita N
    Schizophr Res; 2020 Aug; 222():122-132. PubMed ID: 32505446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of
    Iwata Y; Nakajima S; Plitman E; Mihashi Y; Caravaggio F; Chung JK; Kim J; Gerretsen P; Mimura M; Remington G; Graff-Guerrero A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():340-352. PubMed ID: 29580804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
    Plitman E; Chavez S; Nakajima S; Iwata Y; Chung JK; Caravaggio F; Kim J; Alshehri Y; Chakravarty MM; De Luca V; Remington G; Gerretsen P; Graff-Guerrero A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():16-24. PubMed ID: 29414127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
    Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
    JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.
    Iwata Y; Nakajima S; Plitman E; Caravaggio F; Kim J; Shah P; Mar W; Chavez S; De Luca V; Mimura M; Remington G; Gerretsen P; Graff-Guerrero A
    Biol Psychiatry; 2019 Apr; 85(7):596-605. PubMed ID: 30389132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralipid/Heparin Infusion Alters Brain Metabolites Assessed With 1H-MRS Spectroscopy in Young Healthy Men.
    Karczewska-Kupczewska M; Nikolajuk A; Filarski R; Majewski R; Tarasów E
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2563-2570. PubMed ID: 29860500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of neurometabolites between remitted bipolar disorder and depressed bipolar disorder: A proton magnetic resonance spectroscopy study.
    Liu T; Wang Y; Zhong S; Wang B; Liao X; Lai S; Jia Y
    J Affect Disord; 2017 Mar; 211():153-161. PubMed ID: 28126615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
    Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
    Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia.
    Bustillo JR; Jones T; Qualls C; Chavez L; Lin D; Lenroot RK; Gasparovic C
    J Affect Disord; 2019 Mar; 246():745-753. PubMed ID: 30623820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers.
    Prisciandaro JJ; Schacht JP; Prescot AP; Renshaw PF; Brown TR; Anton RF
    Alcohol Clin Exp Res; 2019 Feb; 43(2):221-226. PubMed ID: 30537347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings.
    Thakkar KN; Rösler L; Wijnen JP; Boer VO; Klomp DW; Cahn W; Kahn RS; Neggers SF
    Biol Psychiatry; 2017 Mar; 81(6):525-535. PubMed ID: 27316853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
    Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
    Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myo-inositol, Glutamate, and Glutamine in the Prefrontal Cortex, Hippocampus, and Amygdala in Major Depression.
    Shirayama Y; Takahashi M; Osone F; Hara A; Okubo T
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Mar; 2(2):196-204. PubMed ID: 29560915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
    Chang L; Ernst T; Speck O; Grob CS
    Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI): An In Vivo Proton Magnetic Resonance Spectroscopy (1H-MRS) Study.
    Veeramuthu V; Seow P; Narayanan V; Wong JHD; Tan LK; Hernowo AT; Ramli N
    Acad Radiol; 2018 Sep; 25(9):1167-1177. PubMed ID: 29449141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
    Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. J-difference-edited MRS measures of γ-aminobutyric acid before and after acute caffeine administration.
    Oeltzschner G; Zöllner HJ; Jonuscheit M; Lanzman RS; Schnitzler A; Wittsack HJ
    Magn Reson Med; 2018 Dec; 80(6):2356-2365. PubMed ID: 29752742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction.
    Chang L; Friedman J; Ernst T; Zhong K; Tsopelas ND; Davis K
    Biol Psychiatry; 2007 Dec; 62(12):1396-404. PubMed ID: 17693392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.